Cardiovascular Systems Announces First Patients Treated in United States with OrbusNeich Teleport Microcatheter Medical Device Investing
NanoVibronix Announces Expanded Agreement with MDS Pharm to Include Distribution of UroShield in Israel Medical Device Investing
Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy Pharmaceutical Investing
BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin Pharmaceutical Investing
Dr. Reddy’s Laboratories Launches Aspirin and Extended-Release Dipyridamole Capsules in the U.S. Market Life Science Investing
Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for New NARCAN Nasal Spray Patent Life Science Investing
